Tiny Technology Promising For MS | Chemical & Engineering News
Volume 90 Issue 48 | p. 31 | Concentrates
Issue Date: November 26, 2012 | Web Date: November 27, 2012

Tiny Technology Promising For MS

When injected into mice with multiple sclerosis symptoms, peptide-coated particles halt progression of the disease
Department: Science & Technology
News Channels: Biological SCENE
Keywords: multiple sclerosis, nanoparticles, immune disorder, myelin, immune tolerance, peptides

Nanoscale particles made of the biodegradable copolymer poly(lactide-co-glycolide) might one day help treat autoimmune diseases such as multiple sclerosis (MS), according to a report (Nat. Biotechnol., DOI: 10.1038/nbt.2434). MS occurs when the body’s own immune system attacks myelin—a mixture of lipids and proteins that insulate nerve fibers and assist nerve signal transmission. A research team led by Stephen D. Miller and Lonnie D. Shea of Northwestern University has designed and tested injectable 500-nm peptide-coated particles of this material as well as polystyrene. The particles are coated in myelin peptide segments (antigens) that, when presented to immune cells such as T cells, induce tolerance to the nerve material and halt the progression of MS symptoms in mice. By injecting peptide-coated particles into mice seven days before the normal onset of MS symptoms, the researchers completely protected the rodents from disease. Shea says the team plans to also test the technology on other immune disorders such as asthma.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment